Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy
Elise M. N. Ferré(National Institutes of Health), Michail S. Lionakis(National Institute of Allergy and Infectious Diseases), Gülbû Uzel(National Institutes of Health), Amy P. Hsu(National Institute of Allergy and Infectious Diseases), Muthulekha Swamydas(Cleveland Clinic Lerner College of Medicine), David E. Kleiner(National Institutes of Health), Shakuntala Rampertaap(National Institutes of Health Clinical Center), Timothy J. Break(Meso Scale Discovery (United States)), Joseph Monsale(National Institutes of Health Clinical Center), Heidi H. Kong(National Institutes of Health), Niki M. Moutsopoulos(National Institute of Allergy and Infectious Diseases), Ariane Soldatos(National Institute of Neurological Disorders and Stroke), Cathleen Frein(Leidos (United States)), Stacey Rose(National Institute of Allergy and Infectious Diseases), Peter D. Burbelo(National Institutes of Health), Ilias Alevizos(Amgen (United States)), Mukil Natarajan(National Institute of Allergy and Infectious Diseases), Sarah Browne(National Institute of Allergy and Infectious Diseases), Jeffrey B. Kopp(National Institute of Diabetes and Digestive and Kidney Diseases), Katherine R. Calvo(National Institutes of Health Clinical Center), Kimberly Romito(National Institutes of Health Clinical Center), Rachel Bishop(National Eye Institute), Amanda L. Collar(National Institute of Allergy and Infectious Diseases), Sergio D. Rosenzweig(National Institutes of Health), Steven M. Holland(National Institute of Allergy and Infectious Diseases), Lindsey B. Rosen(National Institute of Allergy and Infectious Diseases), Anamaria Bondici(National Institute of Allergy and Infectious Diseases), Julie E. Niemela(National Institutes of Health Clinical Center), Lynne Yockey(National Institutes of Health), Theo Heller(National Institutes of Health), David M. Chascsa(National Institute of Diabetes and Digestive and Kidney Diseases), Morgan Similuk, Thomas A. Fleisher(National Institutes of Health Clinical Center), Thomas L. Simcox(National Institute of Diabetes and Digestive and Kidney Diseases), Sally Hunsberger(National Institute of Allergy and Infectious Diseases), Karen K. Winer(Eunice Kennedy Shriver National Institute of Child Health and Human Development), Wenjuan Gu(Leidos (United States)), Martha Quezado, Jennifer Adjemian, Kelly D. Stone(National Institutes of Health), David M. Lang(Cleveland Clinic), Chyi‐Chia Richard Lee(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Kenneth N. Olivier(University of North Carolina at Chapel Hill), Angela Pham(National Institute of Allergy and Infectious Diseases)
Cited by 304
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
|New England Journal of Medicine|2010|3.3k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
|The Lancet|2014|2.2k
Activated STING in a Vascular and Pulmonary Syndrome
|New England Journal of Medicine|2014|1.4k